Vasorelaxation and superoxide scavenging activities of orotic acid

International Journal of Pharmacology

Volumn 6, Issue 4, 2010, Pages 375-380

  Prachayasittikul, S ^a   Wongsawatkul, O ^a   Worachartcheewan, A ^b   Ruchirawat, S ^c   Prachayasittikul, V ^b  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c CHULABHORN RESEARCH INSTITUTE   (Thailand)

Author keywords

Antioxidants; Indomethacin; L NAME; Nitric oxide; Orotic acid; Prostacyclin; Vasorelaxants

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ACETYLCHOLINE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OROTIC ACID; PROSTACYCLIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; DRUG STRUCTURE; ENDOTHELIUM CELL; MALE; NONHUMAN; RAT; THORACIC AORTA; VASODILATATION;

EID: 77955644960     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bhattachaiyya, M. and P. Nandy, 1989. Vasodilatoiy effect of nicotinamide on the fluidity of erythrocyte membrane and liposomes. J. Surf. Sci. Technol., 5: 13-20.
2. Busarakumtragul, P., P. Tep-areenan, S. Chainakul and O. Wongsawatkul, 2010. Effects of barakol on vascular functions in rats. Int. J. Pharmacol., 6: 257-263.
3. Classen, H.G., 2004. Magnesium orotate-experimental and clinical evidence. Rom. J. Int. Med., 42: 491-502.
4. Dalbó, S., E.G. Moreira, F.C. Brandão, H. Horst, M.G. Pizzolatti, G.A. Micke and R.M. Ribeiro-do-Valle, 2008. Mechanisms underlying the vasorelaxant effect induced by proanthocyanidin-rich fraction from Croton celtidifolius in rat small resistance arteries. J. Pharmacol. Sci., 106: 234-241.
5. + is an endothelium derived hyperpolarizing factor in rat arteries. Nature, 396: 269-272.
6. + channels and sodium pump in the vasodilation induced by acetylcholine, nitric oxide and cyclic GMP in the rabbit aorta. Gen. Pharmacol., 33: 35-41.
7. Grey, M., S. Yainoy, V. Prachayasittikul andL. Bülow, 2009. A superoxide dis mutase-human hemoglobin fusion protein showing enhanced antioxidative properties. FEBS J., 276: 6195-6203.
8. Guler, N., O. Hanefi and E. Beyhan, 2006. Vasorelaxant effect of sildenafil on aorta and pulmonary artery in rabbits. Int. J. Pharmacol., 2: 55-59.
9. Lai, E., I. de Lepeleire, T.M. Crumley, F. Liu and L.A. Wenning et al., 2007. Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. Clim. Pharmacol. Ther., 81: 849-857.
10. B receptors in airway epithelium. Am. J. Respir. Cell Mol. Biol., 39: 296-304.
11. Monks, M., S. Ibanez, C. Evangelisti and S. Gohla, 2005. Cosmetic or dermatological preparation comprising a nutrient medium phase and uses for physiological wound healing or scar reduction. US Patent 249691, Chem. Abstr., 143: 446260.
12. Morrow, J.D., W.G. Parsons and L.J. Roberts, 1989. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins, 38: 263-274.
13. Nagayama, M., F. Zhang and C. Iadecola, 1998. Delay treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. J. Cereb. Blood Flow Metab., 18: 1107-1113.
14. Norton, C., A.Z. Kalea, P.D. Harris and D.J.K. Zacas, 2005. Wild blueberry-rich diets affect the contractile machinery of the vascular smooth muscle in the Sprague-Dawley rat. J. Med. Food, 8: 8-13.
15. Piccinelli, A.L., S. Arana, A. Caceres, R. Di-villa-Bianca, R. Sorrentino andL. Rastrelli, 2004. New lignans from the roots of Valeriana prionophylla with antioxidative and vasorelaxant activities. J. Nat. Prod., 67: 1135-1140.
16. Prachayasittikul, S., S. Suphapong, A. Worachartcheewan, R. Lawung, S. Ruchirawat and V. Prachayasittikul, 2009. Bioactive metabolites from Spilanthes acmella Murr. Molecules, 14: 850-867.
17. Prachayasittikul, S., O. Wongsawatkul, A. Worachartcheewan, C. Nantasenamat, S. Ruchirawat and V. Prachayasittikul, 2010. Elucidating the structure-activity relationships of the vasorelaxation and antioxidation properties of thionicotinic acid derivatives. Molecules, 15: 198-214.
18. Quignard, J.F., M. Félétou, S{cyrillic}. Thollon, J.P. Vilaine, J. Duhault and P.M. Vanhoutte, 1999. Potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig carotid and porcine coronary arteries. Br. J. Pharmacol., 127: 27-34.
19. Rodriguez, R.R., M.D. Herrera, J.S. Perona and V.R. Gutiérrez, 2004. Potential vasorelaxant effects of oleanolic acid and erythrodiol, two triterpenoids contained in orujo olive oil, on rat aorta. Br. J. Nutr., 92: 635-642.
20. Rosenfeldt, F.L., 1998a. Editorial: Metabolic supplementation with orotic and magnesium orotate. Cardiovasc. Drugs Ther., 12: 147-152.
21. Rosenfeldt, F.L., S.M. Richards, Z. Lin, S. Pepe and R.A.J. Conyers, 1998b. Mechanism of cardioprotective effect of orotic acid. Cardiovasc. Drugs Ther., 12: 159-170.
22. Sherwood, S., D.A. Jenkins and S.A. Rittmanic, 2007a. Protein beverage and method of making the same. US Patent 148305, Chem. Abstr., 147: 94678.
23. Sherwood, S., D.A. Jenkins and S.A. Rittmanic, 2007b. Protein beverage and method of making the same. US Patent 154614, Chem. Abstr., 147: 94663.
24. Villa, I.C., R. Vera, M. Galisteo, F. O'Valle, M. Romero, A. Zarzuelo and J. Duarte, 2005. Endothelial nitric oxide production stimulated by bioflavonoid chiysin in rat isolated arota. Planta. Med., 71: 829-834.
25. Woerwag, F., 1997. Use of orotic acid to protect endothelial membrances. Patent No. DE 19530300, Chem. Abstr., 126: 166495.
26. Wongsawatkul, O., S. Prachayasittikul, C. Isarankura-Na-Ayudhya, J. Satayavivad, S. Ruchirawat and V. Prachayasittikul, 2008. Vasorelaxant and antioxidant activities of Spilanthes acmella murr. Int. J. Mol. Sci., 9: 2724-2744.
27. + channels to acetylcholine-induced dilatation of rat conduit and resistance arteries. Clin. Exp. Pharmacol. Physiol., 27: 34-40.
28. Zardi, E.M., A. Dobrina, A. Amoroso and A. Afeltra, 2007. Prostacyclin in liver disease: A potential therapeutic option. Expert Opin. Biol. Ther., 7: 785-790.
29. Zeana, C., 1999. Magnesium orotate in myocardial and neuronal protection. Rom. J. Int. Med., 37: 91-97.